tirzepatide constipation side effect vs. Semaglutide: What You Should Know Tirzepatide Side Effects Guide: Safety

This double-blind, placebo-controlled trial randomized (1:1) adults with body mass index 30 or 27 kg/m 2 and at least one obesity-related complication (excluding diabetes), who achieved 5.0% weight reduction after a 12-week intensive lifestyle intervention, to tirzepatide maximum tolerated dose (10 or 15 mg) or placebo once weekly for 72 weeks ( n = 579)

In clinical trials, Tirzepatide has been administered for up to 52 weeks, with studies extending up to 72 weeks

Companion Supplies & Routine Support Confirm before using a vial Compounded tirzepatide can arrive with different concentrations, beyond-use dates, and storage instructions

Handle using appropriate laboratory safety procedures and personal protective equipment